Drugs & Medicine Recalls

Pharmaceutical recall notices, chemical impurities, and biological contamination.

Showing 24 of 421 results
Pharmaceutical
FDA DrugsClass II

Discount Drug Mart Food Market, Cough Drops, Menthol -Cough Suppressant Anesthet...

This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on product quality.

Apr 22, 2026Xiamen Kang Zhongyuan Biotechnology Co., Ltd.
Pharmaceutical
FDA DrugsClass II

QC Quality Choice, Menthol-Cough Suppressant Oral Anesthetic, Cough Drops, Sugar...

This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on product quality.

Apr 22, 2026Xiamen Kang Zhongyuan Biotechnology Co., Ltd.
Pharmaceutical
FDA DrugsClass II

Cinacalcet Hydrochloride Tablets, 30 mg, 30 Tablets per bottle, Rx Only, Manufac...

CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit

Apr 22, 2026Cipla USA, Inc.
Pharmaceutical
FDA DrugsClass II

QC Quality Choice, Menthol- Cough Suppressant Oral Anesthetic, Cough Drops, Cher...

This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on product quality.

Apr 22, 2026Xiamen Kang Zhongyuan Biotechnology Co., Ltd.
Pharmaceutical
FDA DrugsClass II

Lidocaine HCl Injection, USP, 2%, 100 mg/5mL (20 mg/mL), 5 mL Single-Dose Vials,...

Lack of Assurance of Sterility

Apr 22, 2026Huons Co., Ltd.
Pharmaceutical
FDA DrugsClass II

exchange select, Menthol -Cough Suppressant Oral Anesthetic, Honey Lemon Flavor ...

This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on product quality.

Apr 22, 2026Xiamen Kang Zhongyuan Biotechnology Co., Ltd.
Pharmaceutical
FDA DrugsClass II

HydroPeptide CLEAR ALLIANCE SERUM, 2.5% BENZOYL PEROXIDE, a)1 FL OZ/30ml; b) 2 F...

Chemical contamination: Presence of benzene

Apr 22, 2026Owen Biosciences Inc.
Pharmaceutical
FDA DrugsClass II

exchange select, Menthol- Cough Suppressant Oral Anesthetic, Cough Drops, Mentho...

This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on product quality.

Apr 22, 2026Xiamen Kang Zhongyuan Biotechnology Co., Ltd.
Pharmaceutical
FDA DrugsClass II

Albuterol Sulfate Inhalation Solution, 0.5%, 25 mg/5 mL (5 mg/mL*), 30x5 mL Ster...

Labelling: Illegible label

Apr 22, 2026Nephron SC, LLC
Pharmaceutical
FDA DrugsClass III

Magnesium Chloride, 6-Hydrate, Crystal, 500G per bottle, Bulk active pharmaceuti...

Subpotent drug

Apr 22, 2026Avantor Performance Materials LLC
Pharmaceutical
FDA DrugsClass II

EPINEPHRINE Injection, USP, 1 mg/10mL (0.1 mg/mL), Rx only, INTERNATIONAL MEDICA...

Lack of Assurance of Sterility

Apr 22, 2026International Medication Systems Ltd.
Pharmaceutical
FDA DrugsClass II

Memantine Hydrochloride Extended-Release, Capsules, 7 mg, 100 Capsules (10 x 10 ...

Failed Dissolution Specifications

Apr 22, 2026The Harvard Drug Group LLC
Pharmaceutical
FDA DrugsClass II

SLMD BP Acne Spot Treatment, 10% Benzoyl Peroxide, 0.5 fl. oz - 15 mL bottles, S...

Chemical contamination: Presence of benzene

Apr 22, 2026Owen Biosciences Inc.
Pharmaceutical
FDA DrugsClass II

QC Quality Choice, Menthol- Cough Suppressant Oral Anesthetic, Cough Drops, Suga...

This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on product quality.

Apr 22, 2026Xiamen Kang Zhongyuan Biotechnology Co., Ltd.
Pharmaceutical
FDA DrugsClass II

QC Quality Choice, Menthol-Cough Suppressant Oral Anesthetic, Cough Drops, Honey...

This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on product quality.

Apr 22, 2026Xiamen Kang Zhongyuan Biotechnology Co., Ltd.
Pharmaceutical
FDA DrugsClass III

Essential Calming Skin Gel, hydrocortisone 1%, 120mL/4oz net wt. (113g) per jar,...

Subpotent Drug

Apr 22, 2026Island Kinetics, Inc. d.b.a. CoValence Laboratories
Pharmaceutical
FDA DrugsClass II

QC Quality Choice, Pectin Oral Demulcent, Throat Soothing Drops, Creamy Strawber...

This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on product quality.

Apr 22, 2026Xiamen Kang Zhongyuan Biotechnology Co., Ltd.
Pharmaceutical
FDA DrugsClass II

Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg, 1 MG/ML, 0.5 mL via...

Lack of Assurance of Sterility

Apr 22, 2026PAYLESS COMPOUNDERS, LLC
Pharmaceutical
FDA DrugsClass II

0.9% Sodium Chloride Injection, USP 900 mg per 100 mL (9 mg per mL), 1,000 mL in...

Lack of Assurance of Sterility

Apr 15, 2026Fresenius Kabi USA, LLC
Pharmaceutical
FDA DrugsClass II

Vancomycin HCI, 1.5 grams added to 250 mL, 0.9% Sodium Chloride Injection USP, F...

Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port

Apr 15, 2026Fagron Compounding Services
Pharmaceutical
FDA DrugsClass II

0.9% Sodium Chloride Injection, USP, (4,500 mg per 500 mL) (9 mg per mL) 500 mL ...

Lack of Assurance of Sterility

Apr 15, 2026Fresenius Kabi USA, LLC
Pharmaceutical
FDA DrugsClass II

Vancomycin HCI, 1.25 grams added to 250 mL, 0.9% Sodium Chloride Injection USP, ...

Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port

Apr 15, 2026Fagron Compounding Services
Pharmaceutical
FDA DrugsClass II

0.9% Sodium Chloride Injection, USP, 900 mg per 100 mL (9 mg per mL) 100 mL in a...

Lack of Assurance of Sterility

Apr 15, 2026Fresenius Kabi USA, LLC
Pharmaceutical
FDA DrugsClass II

Lanreotide Injection, 120 mg/0.5 mL, Box contains 1 Pre-filled syringe, Single d...

Lack of Assurance of Sterility: Due to an FDA observation at the contract manufacturing site for deficiencies in their visual inspection procedure.

Apr 15, 2026Cipla USA, Inc.